DOCS News and Press, Doximity Inc. Class A From 10/10/25

2025-10-10 11:08:59 ET More on Doximity Doximity: Valuation Is Too Expensive For My Liking Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript Doximity: Slowing Sales And EBITDA Growth Doximity, LivaNova downgraded as Goldman Sachs reviews MedTech and Heal...

2025-10-08 08:38:20 ET from Evercore ISI issued a price target of $81.00 for DOCS on 2025-10-08 12:11:46. The adjusted price target was set to $81.00. At the time of the announcement, DOCS was trading at $71.38. The overall price target consensus is at $67.60 with high p...

2025-10-01 13:57:07 ET More on Doximity, LivaNova PLC, etc. Doximity: Valuation Is Too Expensive For My Liking LivaNova PLC (LIVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Beta Bionics, Inc. (BBNX) Presents At Morgan Stanley 23rd...

2025-09-20 01:05:17 ET Investment action Read the full article on Seeking Alpha For further details see: Doximity: Valuation Is Too Expensive For My Liking

2025-08-27 23:04:11 ET This article is part of a series that provides an ongoing analysis of the changes made to Fundsmith's 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 08/14/2025. Please visit our Tracking Terry Smith's Fundsmith 13F Port...

2025-08-08 07:41:44 ET More on Doximity Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript Doximity: Slowing Sales And EBITDA Growth Doximity Crushes The Rule Of 40 - Try Rule Of 58 Doximity outlines 11% full-year revenue growth target as AI suite and Pat...

2025-08-07 21:51:09 ET More on Doximity Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript Doximity: Slowing Sales And EBITDA Growth Doximity Crushes The Rule Of 40 - Try Rule Of 58 Doximity Non-GAAP EPS of $0.36 beats by $0.05, revenue of $145.9M beats b...

2025-08-07 21:50:32 ET Doximity, Inc. (DOCS) Q1 2026 Earnings Conference Call August 07, 2025, 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Perry Scott Gold - Head of Investor Relatio...

2025-08-07 16:03:44 ET More on Doximity Doximity: Slowing Sales And EBITDA Growth Doximity Crushes The Rule Of 40 - Try Rule Of 58 Doximity: A Unique, Debt-Free Healthcare-Tech Platform; Initiate With 'Buy' Biggest stock movers Friday: SPCE, AMAT, and more ...

Total revenues of $145.9 million, up 15% year-over-year Operating cash flow of $62.1 million, up 51% year-over-year Free cash flow of $60.1 million, up 52% year-over-year Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announ...